Table 1.
Dysfunctions of exosomal IncRNAs in NSCLC.
| Exosomal lncRNAs | Sample | Origin | Expression | Function | References |
|---|---|---|---|---|---|
| MALAT1 | Serum, culture medium | NSCLC cells | Increased | Promote proliferation, invasion and migration, and reduce apoptosis | 23, 82 |
| HOTAIR | Serum, culture medium | Lung cancer cells | Increased | Promote proliferation, invasion and migration | 83, 84 |
| LINC00662 | Plasma | NSCLC cells | Increased | Promote proliferation, cell cycle arrest, invasion, and migration, and inhibit apoptosis | 85 |
| UFC1 | Serum | NSCLC cells | Increased | Promote proliferation, cell cycle arrest, invasion, and migration, and inhibit apoptosis | 86 |
| FOXD3-AS1 | Culture medium | NSCLC cells | Increased | Promote proliferation and invasion, and inhibit apoptosis caused by 5-FU | 87 |
| SCIRT | Malignant pleural effusions (MPEs), plasma, culture medium | NSCLC and SCLC cells | Increased | Promote invasion and migration | 89 |
| lnc-MMP2-2 | Culture medium | TGF-β-mediated NSCLC cells | Increased | Promote invasion, migration and brain metastasis, and reduce permeability of vascular endothelial cells | 91-96 |
| SOX2-OT | Peripheral blood | NSCLC cells | Increased | Promote invasion, migration, bone metastasis and facilitate M2 macrophage polarization | 97, 121 |
| GAS5 | Serum, culture medium | NSCLC cells | Decreased | Promote tumor angiogenesis | 104-106 |
| H19 | Culture medium | NSCLC cells | Increased | Promote gefifitinib resistance | 111 |
| UCA1 | Culture medium | Gefitinib-resistant NSCLC cells | Increased | Promote gefifitinib resistance | 112 |
| RP11-838N2.4 | Serum, culture medium | Eelotinib-resistant NSCLC cells | Increased | Promote erlotinib resistance | 113 |
| MSTRG.292666.16 | Plasma, culture medium | Osimertinib-resistant NSCLC cells | Increased | Promote osimertinib resistance | 114 |
| LINC00313 | Culture medium | NSCLC cells | Increased | Promote M2 macrophage polarization | 120 |
| HOTAIRM1 | Culture medium | NSCLC cells | Increased | Be associated with CAFs | 122 |
| lnc-MZT2A-5:1 | Culture medium | Osimertinib-resistant NSCLC cells | Increased | Promote the migration and inflammation of fibroblasts | 123 |